Use of Rotarix temporarily suspended, no health risks seen

The Food and Drug Administration (FDA) has recommended that U.S. clinicians and public health professionals temporarily suspend the use of Rotarix (GlaxoSmithKline Biologicals, King of Prussia, Pa.), after porcine circovirus-1 (PCV1) DNA was identified in the rotavirus vaccine. There is no evidence